Projects

Lung cancer in Europe: the way forward

Lung cancer in Europe: the way forward

For too long, lung cancer has not been given the policy attention it deserves. The implementation of Europe's Beating Cancer Plan offers a chance to remedy this.

View Project

Prioritising non-communicable diseases in post-pandemic recovery

Prioritising non-communicable diseases in post-pandemic recovery

HPP developed a think piece exploring whether European governments are giving sufficient attention to non-communicable diseases in their post-COVID-19 recovery plans

View Project

Flu vaccination during the COVID-19 pandemic

Flu vaccination during the COVID-19 pandemic

There is a strong case for dedicating resources to secure timely flu vaccination of vulnerable groups and overcome the barriers posed by the COVID-19 pandemic.

View Project

Lung cancer screening: the cost of inaction

Lung cancer screening: the cost of inaction

Improving early detection of lung cancer via targeted screening has the potential to drastically reduce the burden of the world’s leading cause of cancer deaths.

View Project

Secondary prevention of heart attack and stroke

Secondary prevention of heart attack and stroke

HPP consulted experts from 11 countries to develop a consensus report and country profiles exploring prevention of recurrent heart attacks and strokes among high‑risk groups.

View Project

Harnessing data for better cancer care

Harnessing data for better cancer care

HPP and The Health Value Alliance partnered with All.Can International to produce a policy report on the value that high-quality data bring to every aspect of cancer care.

View Project

MS Barometer 2020

MS Barometer 2020

HPP was commissioned by the European MS Platform to develop a report and national factsheets based on the findings of a survey of MS societies in 35 countries across Europe.

View Project

Health system sustainability and resilience

Health system sustainability and resilience

HPP developed two case studies, on lung cancer screening and heart failure, for the Partnership for Health System Sustainability and Resilience’s global summit in March 2021.

View Project

Fragility Fracture Network policy toolkit

Fragility Fracture Network policy toolkit

HPP supported the Fragility Fracture Network to produce policy and clinical toolkits for the FFN Global Call to Action.

View Project

Brain tumours and COVID‑19

Brain tumours and COVID‑19

HPP co-authored a lay summary of survey findings from the International Brain Tumour Alliance and Society for Neuro-Oncology on how COVID-19 has affected brain tumour patients and carers around the world.

View Project

Achieving optimal care for women of childbearing age living with chronic diseases

Achieving optimal care for women of childbearing age living with chronic diseases

The lack of evidence around medication use in pregnancy leaves many women with chronic diseases facing difficult choices about whether, and how, to start a family.

View Project

Adapting health and social care in the wake of COVID‑19

Adapting health and social care in the wake of COVID‑19

In June 2020, HPP developed a think piece exploring areas in which gaps exposed by the COVID-19 pandemic could be addressed to help build more robust health and social care systems.

View Project

Osteoporosis and fragility fractures

Osteoporosis and fragility fractures

Osteoporosis is a chronic disease that weakens bones and leaves people at risk of a fragility fracture. It is expected to become more common in Europe as populations age.

View Project

Radioligand therapy

Radioligand therapy

Radioligand therapy is an innovative approach to treating certain types of cancer. It delivers radiation to specifically targeted cancer cells, with a minimal effect on healthy cells.

View Project

Thyroid disorders in Latin America

Thyroid disorders in Latin America

Thyroid disorders occur when the thyroid gland produces insufficient or excess thyroid hormones. They can be particularly harmful for older people or pregnant women.

View Project

Rethinking MS

Rethinking MS

Multiple sclerosis is a neurological disorder that places unique challenges on health and social care systems, which must work together to ensure the needs and goals of every person with MS are met.

View Project

A life-course approach to immunisation

A life-course approach to immunisation

Programmes that support immunisation across the life course can improve population health and promote health system sustainability. International examples of best practice offer valuable lessons for implementing policies that support immunisation throughout life.

View Project

NASH Non-alcoholic steatohepatitis

NASH Non-alcoholic steatohepatitis

The progressive form of non‑alcoholic fatty liver disease, known as non‑alcoholic steatohepatitis NASH, is a growing concern as the global prevalence of obesity and type 2 diabetes continues to rise.

View Project

Genetic testing for <i>BRCA</i> mutations

Genetic testing for BRCA mutations

Genetic mutations in the BRCA1 and BRCA2 genes can significantly increase the risk of some cancers, but many people across Europe lack access to genetic testing.

View Project

A sustainable approach to depression

A sustainable approach to depression

Depression is on the rise, but the policy response so far has been insufficient. Huge gaps in care and underfunding of mental health services are areas that need to be addressed.

View Project

All.Can: changing cancer care together

All.Can: changing cancer care together

All.Can is an international initiative working to improve efficiency in cancer care by focusing on what matters to patients.

View Project

Atrial fibrillation and AF‑related stroke

Atrial fibrillation and AF‑related stroke

Atrial fibrillation is a common condition and leading cause of stroke, yet it is widely under-recognised. People across Europe face significant inequalities in access to detection and treatment.

View Project

Radiotherapy

Radiotherapy

As the incidence of cancer increases, health systems must find effective and sustainable ways to care for all cancer patients. Radiotherapy is a key part of this.

View Project

Viral hepatitis in Asia Pacific

Viral hepatitis in Asia Pacific

Global deaths from viral hepatitis continue to rise and more than 60% occur in the Asia Pacific region.

View Project

Life-course vaccination

Life-course vaccination

Vaccination is vital to improve population health throughout life – but despite strong evidence, it is misunderstood and undervalued.

View Project

Childhood epilepsy

Childhood epilepsy

The needs of children with epilepsy who experience prolonged convulsive seizures have been neglected. Without effective treatment, these children are at serious risk.

View Project

Sarcoma policy checklist

Sarcoma policy checklist

Despite recent advances in research and treatment, people with sarcoma report some of the poorest experiences of care among cancer patients

View Project

Rare diseases: shaping a future with no-one left behind

Rare diseases: shaping a future with no-one left behind

Rare diseases affect up to 400 million people across the world – and, for many, there are no treatment options available.

View Project

RARECARENet

RARECARENet

Rare cancers represent almost a quarter of new cancer diagnoses in Europe – so improving patient outcomes should be a public health priority.

View Project

The state of play in person-centred care

The state of play in person-centred care

A person-centred approach can transform how people experience care, but a lack of common definitions and terminology may hinder its use in practice.

View Project

Load More